fda glp-1 compounding warning september 2025 and Novo Nordisk Warned of Telehealth Takedown. What's Next? FDA Targets GLP-1 and Peptide

Our weight loss injections help burn fat fast

This question concerns many patients prescribed glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) for type 2 diabetes or weight management

We saw widespread shortages with Wegovy and Zepbound

The effectiveness of oral versions varies by specific product and formulation, and understanding the differences between injectable and oral delivery helps inform this decision

Moreover, GLP-1R activation counteracts the effects of -adrenoceptor stimulation on cardiac ventricular excitability and reduces ventricular arrhythmic potential [165]